Brineura

Active Ingredient(s): Cerliponase Alfa
FDA Approved: * April 27, 2017
Pharm Company: * BIOMARIN PHARM
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Recent Brineura Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cerliponase Alfa
  • Injection: 30mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Brineura: (1 result)

Sorted by National Drug Code
  • 68135-811 Brineura Intraventricular Kit by Biomarin Pharmaceutical Inc.

Other drugs which contain Cerliponase Alfa or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 March 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA